The FDA on Wednesday expanded its Cyclospora outbreak investigation, saying 6,358 confirmed cases across 15 states are now tied to exposure at Taco Bell or to Taylor Farms de Mexico iceberg lettuce. For clinicians, that means a large multistate foodborne outbreak of intestinal infectious diseases remains active despite a recall, with 278 hospitalizations and two deaths reported in Michigan.

The Move

• The Food and Drug Administration said additional interview data linked outbreak cases to Taco Bell and to recalled Taylor Farms de Mexico iceberg lettuce.

• The outbreak began June 22, and Taylor Farms de Mexico voluntarily recalled all lettuce sourced from central Mexico on July 17.

• Six states were newly added since the FDA’s July 24 update: Arkansas, Iowa, Missouri, Nebraska, New Hampshire and North Carolina.

Why It Matters for Care

• Patients with severe diarrhea, abdominal cramping, nausea, fatigue or weight loss after eating implicated lettuce may have cyclosporiasis rather than a routine viral gastroenteritis.

• Symptoms typically begin about one week after infection and can last days to a month, sometimes resolving and then recurring.

• The FDA and CDC note some people are asymptomatic, so exposure history matters when evaluating household clusters or prolonged diarrheal illness.

Between The Lines

• Federal officials expect case counts to keep rising even after the recall because confirming outbreak-related illness can take up to six weeks.

• The politics are familiar: food-safety outbreaks quickly become arguments over federal oversight, supply-chain accountability and whether regulators moved fast enough.

• The cross-border sourcing link to central Mexico also puts pressure on import surveillance and traceability in produce distribution.

What To Watch

• Further FDA and CDC updates on case counts, state spread and any expansion beyond Taco Bell or currently identified lettuce products.

• Whether more retailers or packaged salad brands are added; the FDA has already urged disposal of Marketside-branded products sold in 27 states in early July.

• For bedside practice, watch for local public health alerts and testing guidance as clinicians report suspected cases tied to the outbreak.

Source: Fox News